Concentric Analgesics
Jonathan R. Lynch currently manages Incisive Capital, which participated as the leading new investor in the company’s Dec2021 convertible note financing. Mr. Lynch founded and previously served as a Managing Director and Investment Committee member of CCMP Capital Advisors, LLC (successor to JPMorgan Partners). At CCMP, he focused principally on private equity investments in the consumer and business services sectors. Prior to joining CCMP in 1992, Mr. Lynch was a member of the Mergers and Acquisitions department of Prudential Securities and is a past president of the Venture Investors Association of NY (VIANY). He graduated magna cum laude with a B.S. from Georgetown University and holds an MBA from Harvard Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Concentric Analgesics
Concentric Analgesics, Inc. is a private, biotechnology company focused on discovering and developing novel, non-opioid therapeutics for the management of acute and chronic pain.